W Al Sarakbi

514 citations
11 papers · 371 indexed · h-index 8
Topics
Estrogen and related hormone effects (4 papers)Breast Lesions and Carcinomas (3 papers)Cancer Risks and Factors (2 papers)

In The Last Decade

W Al Sarakbi

11 papers receiving 364 citations

Peers

W Al Sarakbi
Comparison fields: 5 of 62
  • Molecular Biology 128
  • Oncology 113
  • Cancer Research 108
  • Pathology and Forensic Medicine 106
  • Surgery 68
Replace Hideaki Aoyama with:
Hideaki Aoyama Japan
Katie A. Ashton Australia
Shigeru Tsuyuki Japan
Rolf Kaaresen Norway
Panagiota Tsioli Greece
King Xin Koh Singapore
Woo Gyeong Kim South Korea
Keystone Ec Canada
H Soliman France
Kazuma Maeno Japan
W Al Sarakbi relative to Hideaki Aoyama Japan Hideaki Aoyama's profile →
Citations per field
00.5×
Hideaki Aoyama · 1×
Citations per year

Countries citing papers authored by W Al Sarakbi

Since Specialization
Citations

This map shows the geographic impact of W Al Sarakbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Al Sarakbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Al Sarakbi more than expected).

Fields of papers citing papers by W Al Sarakbi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Al Sarakbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Al Sarakbi. The network helps show where W Al Sarakbi may publish in the future.

Co-authorship network of co-authors of W Al Sarakbi

This figure shows the co-authorship network connecting the top 25 collaborators of W Al Sarakbi. A scholar is included among the top collaborators of W Al Sarakbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Al Sarakbi. W Al Sarakbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1
Evidence of an autocrine role for leptin and leptin receptor in human breast cancer.
13
2 98
3
The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
49
4 5
5 59
6 32
7 1
8
Dairy products and breast cancer risk: a review of the literature.
10
9 7
10 71
11 26

About W Al Sarakbi

W Al Sarakbi is a scholar working on Dermatology, Genetics and Pathology and Forensic Medicine, having authored 11 papers that have together received 371 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (4 papers), Breast Lesions and Carcinomas (3 papers) and Cancer Risks and Factors (2 papers). The work is most often cited by research in Cancer Research (108 citations), Pathology and Forensic Medicine (106 citations) and Dermatology (51 citations). W Al Sarakbi has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Kefah Mokbel, M Salhab, Wen G. Jiang, Walid Sasi, Timothy Roberts, R. F. Newbold, Michael Reed, Val Thomas and Umar Wazir. Their work appears in journals such as Breast Cancer Research and Treatment, BMC Cancer and Journal of Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026